
Micafungin injection is the first antifungal drug approved in the United States specifically for pediatric patients younger than 4 years of age with invasive candidiasis.

Micafungin injection is the first antifungal drug approved in the United States specifically for pediatric patients younger than 4 years of age with invasive candidiasis.

Secukinumab provided early and sustained resolution of enthesitis in patients with psoriatic arthritis based on post hoc analysis pooled data from the FUTURE trial.

Through the Automatic LifeStyle Advice platform, health service providers can integrate personal health trackers, allowing data to configure the optimal recommendation for diet, exercise, and daily health management.

Officials with the FDA have approved pembrolizumab (Keytruda, Merck) for the treatment of certain patients with Bacillus Calmette-Guerin-unresponsive, high-risk, non-muscle invasive bladder cancer.

Top news of the day from across the health care landscape.

Study seeks to determine how HIV avoids the zinc-finger antiviral protein and how it binds the RNA.

There are some basic tips or tricks to getting the most out of your insurance plan and to maintain the care patients are accustomed to.

Dietary supplements containing zinc and folic acid marketed as a treatment for male infertility do not appear to improve pregnancy rates.

Manufacturers have selected AllianceRx Walgreens as their limited distribution drug partner for drugs that treat conditions such as myelofibrosis, cystic fibrosis, and non-metastatic castration-resistant prostate cancer.

An effective treatment plan for squamous cell carcinoma best undertaken by a group of practitioners.

The CDC has reported 34800 new cancer diagnoses linked to HPV annually, and the virus is predicted to account for more than 90% of all cervical and anal cancers, more than 60% of all penile cancers, and 70% of all oral cancers.

Top news of the day from across the health care landscape.

Girish Dighe, PharmD, MS, explains why it's important to understand more than just the revenue integrity piece of the puzzle.

Members of the former International Academy of Compounding Pharmacists voted in November 2019 to change the association’s name to the Alliance for Pharmacy Compounding.

Deferasirox is indicated for treating chronic iron overload caused by repeated blood transfusions in patients age 2 years and older.

The Prescription Drug User Fee Act date, the FDA action data for this supplemental application, is scheduled for the second quarter of 2020.

A study suggests that even brief art-making interventions can be beneficial for stressed caregivers of patients with cancer.

Annoying work habits can set the tone for lower productivity and teamwork in the pharmacy.

Top news of the day from across the health care landscape.

Researchers investigate whether on-demand pre-exposure prophylaxis was similarly effective among individuals with lower exposure to HIV risk.

The treatment is the first and only fast-acting mealtime insulin injection that does not have a pre-meal dosing recommendation, according to Novo Nordisk.

According to the study authors, such “anti-austerity agents” represent a promising approach to cancer chemotherapy.

Could tadalafil be causing a patient to feel dizzy?

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times

The study led to insight on the process of tuberculosis bacillus infection as well as a potential drug treatment.

At the recent ASHP (American Society of Health-System Pharmacists) Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada, 3 speakers discussed new developments in influenza management.

The bill would have given the state's superintendent of insurance licensing and regulatory authority over pharmacy benefit managers (PBMs).1

Top news of the day from across the health care landscape.

Novadoz Pharmaceuticals, who markets the product, has commenced shipping of the drug, available in bottles of 30 tablets.